lobbying_activities: 1696207

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1696207	69b673c3-7ceb-41d2-bf35-8b8277f3a00f	Q2	CAPITOL HILL STRATEGIES, LLC	91774	BIOGEN INC	2015	second_quarter	CPT	H.R. 9, Innovation Act (Inter partes review provisions and other provisions relating to patents covered by Hatch-Waxman and Biologics Price Competition and Innovation Act S.632, Support Technology and Research for Our Nation's Growth Patents Act of 2015(BPCIA)).	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2015-07-15T12:38:10.917000-04:00